Related Experiment Video
Updated: May 11, 2026
Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
Published on: November 24, 2014
Successful prevention of no-reflow phenomenon in a high-risk patient using excimer laser coronary atherectomy
Soichiro Ebisawa1, Yusuke Miyashita, Tatsuya Saigusa
1Department of Cardiovascular Medicine, Shinshu University Hospital, Matsumoto, Japan, ebifender@yahoo.co.jp.
Insights
Excimer laser coronary atherectomy (ELCA) can prevent the no-reflow phenomenon, a complication in treating coronary artery disease. This case study highlights ELCA
Area of Science:
- Interventional Cardiology
- Cardiovascular Medicine
- Laser Atherectomy
Background:
- Coronary artery disease treatment aims to prevent myocardial damage.
- The no-reflow phenomenon impairs cardiac muscle viability.
- Excimer laser coronary atherectomy (ELCA) ablates thrombi and necrotic plaques.
Observation:
- A patient presented with severe left ventricular dysfunction and prior extensive anterior infarction.
- The right coronary artery was treated to prevent distal embolism and no-reflow.
Findings:
- ELCA was utilized in the right coronary artery.
- This intervention aimed to prevent the no-reflow phenomenon in a high-risk patient.
Implications:
- ELCA shows potential for preventing distal embolism and no-reflow.
- Further research is warranted on ELCA's role in complex coronary lesions.
- This case expands the understanding of ELCA applications in cardiovascular interventions.
Abstract:
During the treatment of coronary artery disease, the no-reflow phenomenon can lead to severe impairment of viable cardiac muscle and all necessary measures should be taken to prevent it. Excimer laser coronary atherectomy (ELCA) may be indicated for lesions with a large thrombus burden due to potential to ablate thrombi and necrotic plaques. However, there are few reports on the use of ELCA for the prevention of distal embolism. Here, we report a case involving severe left ventricular dysfunction with a previous extensive anterior infarction, where ELCA was used in the right coronary artery to prevent the no-reflow phenomenon.
More Related Videos
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023